“Formulation of Nano-Liposomal Drug Delivery Systems for Targeted Therapy of Multi-Drug-Resistant Tuberculosis (MDR-TB)”, JPEHSS, vol. 4, no. 1, pp. 431–440, Mar. 2026, doi: 10.63163/jpehss.v4i1.1168.